{"id":"https://openalex.org/W3148859331","doi":"https://doi.org/10.1089/cap.2020.0159","title":"Effect of Delayed-Release and Extended-Release Methylphenidate on Caregiver Strain and Validation of Psychometric Properties of the Caregiver Strain Questionnaire: Results from a Phase 3 Trial in Children with Attention-Deficit/Hyperactivity Disorder","display_name":"Effect of Delayed-Release and Extended-Release Methylphenidate on Caregiver Strain and Validation of Psychometric Properties of the Caregiver Strain Questionnaire: Results from a Phase 3 Trial in Children with Attention-Deficit/Hyperactivity Disorder","publication_year":2021,"publication_date":"2021-04-01","ids":{"openalex":"https://openalex.org/W3148859331","doi":"https://doi.org/10.1089/cap.2020.0159","mag":"3148859331","pmid":"https://pubmed.ncbi.nlm.nih.gov/33797983","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/8066344"},"language":"en","primary_location":{"id":"doi:10.1089/cap.2020.0159","doi":"https://doi.org/10.1089/cap.2020.0159","is_oa":true,"landing_page_url":"https://doi.org/10.1089/cap.2020.0159","pdf_url":null,"source":{"id":"https://openalex.org/S198272637","display_name":"Journal of Child and Adolescent Psychopharmacology","issn_l":"1044-5463","issn":["1044-5463","1557-8992"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320443","host_organization_name":"Mary Ann Liebert, Inc.","host_organization_lineage":["https://openalex.org/P4310320443","https://openalex.org/P4310320017"],"host_organization_lineage_names":["Mary Ann Liebert, Inc.","SAGE Publishing"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Child and Adolescent Psychopharmacology","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"hybrid","oa_url":"https://doi.org/10.1089/cap.2020.0159","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5080608380","display_name":"Frank A. L\u00f3pez","orcid":"https://orcid.org/0009-0008-5337-2234","observed_orcids":["https://orcid.org/0009-0008-5337-2234"]},"institutions":[],"countries":[],"is_corresponding":true,"raw_author_name":"Frank A. L\u00f3pez","raw_affiliation_strings":["Pediatric Neurology, P.A., Winter Park, Florida, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pediatric Neurology, P.A., Winter Park, Florida, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5052145058","display_name":"Stephen V. Faraone","orcid":"https://orcid.org/0000-0002-9217-3982","observed_orcids":["https://orcid.org/0000-0002-9217-3982"]},"institutions":[{"id":"https://openalex.org/I20388574","display_name":"SUNY Upstate Medical University","ror":"https://ror.org/040kfrw16","country_code":"US","type":"education","lineage":["https://openalex.org/I20388574"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Stephen V. Faraone","raw_affiliation_strings":["Departments of Psychiatry and of Neuroscience and Physiology, State University of New York (SUNY) Upstate Medical University, Syracuse, New York, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Departments of Psychiatry and of Neuroscience and Physiology, State University of New York (SUNY) Upstate Medical University, Syracuse, New York, USA","institution_ids":["https://openalex.org/I20388574"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5029493957","display_name":"Jeffrey H. Newcorn","orcid":"https://orcid.org/0000-0001-8993-9337","observed_orcids":["https://orcid.org/0000-0001-8993-9337"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Jeffrey H. Newcorn","raw_affiliation_strings":["Mount Sinai Medical Center, New York, New York, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Mount Sinai Medical Center, New York, New York, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5055528194","display_name":"Helen Doll","orcid":"https://orcid.org/0000-0002-1871-8710","observed_orcids":["https://orcid.org/0000-0002-1871-8710"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Helen A. Doll","raw_affiliation_strings":["Clinical Outcomes Assessments, ICON plc, Oxford, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Clinical Outcomes Assessments, ICON plc, Oxford, United Kingdom","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5005307250","display_name":"Stephanie E. Rhoten","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210108991","display_name":"IQVIA (United States)","ror":"https://ror.org/01mk44223","country_code":"US","type":"company","lineage":["https://openalex.org/I4210108991"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Stephanie Rhoten","raw_affiliation_strings":["Current address: IQVIA, San Francisco, California, USA","Patient Centered Outcomes, ICON plc, South San Francisco, California, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Current address: IQVIA, San Francisco, California, USA","institution_ids":["https://openalex.org/I4210108991"]},{"raw_affiliation_string":"Patient Centered Outcomes, ICON plc, South San Francisco, California, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5102873577","display_name":"Hannah B Lewis","orcid":"https://orcid.org/0000-0002-6780-4965","observed_orcids":["https://orcid.org/0000-0002-6780-4965"]},"institutions":[{"id":"https://openalex.org/I4210128688","display_name":"Imperial Consultants","ror":"https://ror.org/0376hjh49","country_code":"GB","type":"company","lineage":["https://openalex.org/I4210128688"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Hannah B. Lewis","raw_affiliation_strings":["Patient Centred Outcomes, ICON plc, London, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Patient Centred Outcomes, ICON plc, London, United Kingdom","institution_ids":["https://openalex.org/I4210128688"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5026215208","display_name":"Tayyaba F. Khan","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Tayyaba F. Khan","raw_affiliation_strings":["Highland Therapeutics, Inc., Toronto, Canada"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Highland Therapeutics, Inc., Toronto, Canada","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5105989420","display_name":"Norberto J. DeSousa","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Norberto J. DeSousa","raw_affiliation_strings":["Ironshore Pharmaceuticals & Development, Inc., Camana Bay, Grand Cayman, Cayman Islands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Ironshore Pharmaceuticals & Development, Inc., Camana Bay, Grand Cayman, Cayman Islands","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112556805","display_name":"Floyd R. Sallee","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Floyd R. Sallee","raw_affiliation_strings":["Ironshore Pharmaceuticals, Inc., Durham, North Carolina, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Ironshore Pharmaceuticals, Inc., Durham, North Carolina, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5057779387","display_name":"Bev Incledon","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Bev Incledon","raw_affiliation_strings":["Ironshore Pharmaceuticals & Development, Inc., Camana Bay, Grand Cayman, Cayman Islands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Ironshore Pharmaceuticals & Development, Inc., Camana Bay, Grand Cayman, Cayman Islands","institution_ids":[]}]},{"author_position":"last","author":{"id":null,"display_name":"On behalf of the HLD200-108 Study Group","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"On behalf of the HLD200-108 Study Group","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":3,"corresponding_author_ids":["https://openalex.org/A5080608380"],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.6194,"has_fulltext":true,"cited_by_count":8,"citation_normalized_percentile":{"value":0.6219042,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":96},"biblio":{"volume":"31","issue":"3","first_page":"179","last_page":"186"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10537","display_name":"Attention Deficit Hyperactivity Disorder","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10537","display_name":"Attention Deficit Hyperactivity Disorder","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11632","display_name":"Family and Disability Support Research","score":0.0,"subfield":{"id":"https://openalex.org/subfields/3203","display_name":"Clinical Psychology"},"field":{"id":"https://openalex.org/fields/32","display_name":"Psychology"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},{"id":"https://openalex.org/T12547","display_name":"Pharmaceutical studies and practices","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2735","display_name":"Pediatrics, Perinatology and Child Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/extended-release-methylphenidate","display_name":"extended-release methylphenidate","score":1.0},{"id":"https://openalex.org/keywords/attention-deficit-hyperactivity-disorder","display_name":"attention deficit hyperactivity disorder","score":0.972000002861023},{"id":"https://openalex.org/keywords/children","display_name":"children","score":0.7160000205039978},{"id":"https://openalex.org/keywords/caregiver-burden","display_name":"caregiver burden","score":0.9789999723434448},{"id":"https://openalex.org/keywords/psychometric-validation","display_name":"psychometric validation","score":0.949999988079071},{"id":"https://openalex.org/keywords/evening-dosing","display_name":"evening dosing","score":0.6470000147819519},{"id":"https://openalex.org/keywords/psychometric-properties","display_name":"psychometric properties","score":0.4560000002384186},{"id":"https://openalex.org/keywords/meaningful-change-thresholds","display_name":"meaningful change thresholds","score":0.7670000195503235},{"id":"https://openalex.org/keywords/responder-definition","display_name":"responder definition","score":0.7160000205039978},{"id":"https://openalex.org/keywords/adhd-symptom-severity","display_name":"ADHD symptom severity","score":0.4090000092983246},{"id":"https://openalex.org/keywords/adhd-rating-scale","display_name":"ADHD Rating Scale","score":0.40400001406669617},{"id":"https://openalex.org/keywords/treatment-response-assessment","display_name":"treatment response assessment","score":0.3050000071525574}],"concepts":[{"id":"https://openalex.org/C2777112843","wikidata":"https://www.wikidata.org/wiki/Q422112","display_name":"Methylphenidate","level":3,"score":0.6956546902656555},{"id":"https://openalex.org/C27081682","wikidata":"https://www.wikidata.org/wiki/Q269829","display_name":"Placebo","level":3,"score":0.6582737565040588},{"id":"https://openalex.org/C106906290","wikidata":"https://www.wikidata.org/wiki/Q1140909","display_name":"Cronbach's alpha","level":3,"score":0.6126496195793152},{"id":"https://openalex.org/C2776000289","wikidata":"https://www.wikidata.org/wiki/Q5133761","display_name":"Clinical Global Impression","level":4,"score":0.5726744532585144},{"id":"https://openalex.org/C104709138","wikidata":"https://www.wikidata.org/wiki/Q1671540","display_name":"Intraclass correlation","level":3,"score":0.5666839480400085},{"id":"https://openalex.org/C2780783007","wikidata":"https://www.wikidata.org/wiki/Q181923","display_name":"Attention deficit hyperactivity disorder","level":2,"score":0.5490118861198425},{"id":"https://openalex.org/C15744967","wikidata":"https://www.wikidata.org/wiki/Q9418","display_name":"Psychology","level":0,"score":0.5371366739273071},{"id":"https://openalex.org/C70410870","wikidata":"https://www.wikidata.org/wiki/Q199906","display_name":"Clinical psychology","level":1,"score":0.4783346652984619},{"id":"https://openalex.org/C168563851","wikidata":"https://www.wikidata.org/wiki/Q1436668","display_name":"Randomized controlled trial","level":2,"score":0.46806657314300537},{"id":"https://openalex.org/C49453240","wikidata":"https://www.wikidata.org/wiki/Q1592163","display_name":"Construct validity","level":3,"score":0.44150179624557495},{"id":"https://openalex.org/C121244757","wikidata":"https://www.wikidata.org/wiki/Q1783487","display_name":"Convergent validity","level":4,"score":0.43421387672424316},{"id":"https://openalex.org/C2780319597","wikidata":"https://www.wikidata.org/wiki/Q1549918","display_name":"Impulsivity","level":2,"score":0.41859757900238037},{"id":"https://openalex.org/C118552586","wikidata":"https://www.wikidata.org/wiki/Q7867","display_name":"Psychiatry","level":1,"score":0.3924400508403778},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.34141114354133606},{"id":"https://openalex.org/C171606756","wikidata":"https://www.wikidata.org/wiki/Q506132","display_name":"Psychometrics","level":2,"score":0.28821253776550293},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.1646277904510498},{"id":"https://openalex.org/C3018868096","wikidata":"https://www.wikidata.org/wiki/Q2693233","display_name":"Internal consistency","level":3,"score":0.10497891902923584},{"id":"https://openalex.org/C204787440","wikidata":"https://www.wikidata.org/wiki/Q188504","display_name":"Alternative medicine","level":2,"score":0.0},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000697","descriptor_name":"Central Nervous System Stimulants","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D001289","descriptor_name":"Attention Deficit Disorder with Hyperactivity","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D002648","descriptor_name":"Child","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D003692","descriptor_name":"Delayed-Action Preparations","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D004311","descriptor_name":"Double-Blind Method","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008774","descriptor_name":"Methylphenidate","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D011594","descriptor_name":"Psychometrics","qualifier_ui":"Q000706","qualifier_name":"statistics & numerical data","is_major_topic":true},{"descriptor_ui":"D011795","descriptor_name":"Surveys and Questionnaires","qualifier_ui":"Q000706","qualifier_name":"statistics & numerical data","is_major_topic":true},{"descriptor_ui":"D015203","descriptor_name":"Reproducibility of Results","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D017028","descriptor_name":"Caregivers","qualifier_ui":"Q000523","qualifier_name":"psychology","is_major_topic":true}],"locations_count":3,"locations":[{"id":"doi:10.1089/cap.2020.0159","doi":"https://doi.org/10.1089/cap.2020.0159","is_oa":true,"landing_page_url":"https://doi.org/10.1089/cap.2020.0159","pdf_url":null,"source":{"id":"https://openalex.org/S198272637","display_name":"Journal of Child and Adolescent Psychopharmacology","issn_l":"1044-5463","issn":["1044-5463","1557-8992"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320443","host_organization_name":"Mary Ann Liebert, Inc.","host_organization_lineage":["https://openalex.org/P4310320443","https://openalex.org/P4310320017"],"host_organization_lineage_names":["Mary Ann Liebert, Inc.","SAGE Publishing"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Child and Adolescent Psychopharmacology","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:8066344","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC8066344/","pdf_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC8066344/pdf/","source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"J Child Adolesc Psychopharmacol","raw_type":"Text"},{"id":"pmid:33797983","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/33797983","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of child and adolescent psychopharmacology","raw_type":"Clinical Trial, Phase III"}],"best_oa_location":{"id":"doi:10.1089/cap.2020.0159","doi":"https://doi.org/10.1089/cap.2020.0159","is_oa":true,"landing_page_url":"https://doi.org/10.1089/cap.2020.0159","pdf_url":null,"source":{"id":"https://openalex.org/S198272637","display_name":"Journal of Child and Adolescent Psychopharmacology","issn_l":"1044-5463","issn":["1044-5463","1557-8992"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320443","host_organization_name":"Mary Ann Liebert, Inc.","host_organization_lineage":["https://openalex.org/P4310320443","https://openalex.org/P4310320017"],"host_organization_lineage_names":["Mary Ann Liebert, Inc.","SAGE Publishing"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Child and Adolescent Psychopharmacology","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":1.0,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W3148859331.pdf","grobid_xml":"https://content.openalex.org/works/W3148859331.grobid-xml"},"referenced_works_count":38,"referenced_works":["https://openalex.org/W217752906","https://openalex.org/W1521375496","https://openalex.org/W1586429020","https://openalex.org/W1948841565","https://openalex.org/W1981631264","https://openalex.org/W2000700955","https://openalex.org/W2021008737","https://openalex.org/W2032535633","https://openalex.org/W2042184165","https://openalex.org/W2055882876","https://openalex.org/W2061701807","https://openalex.org/W2087103760","https://openalex.org/W2091598844","https://openalex.org/W2092608254","https://openalex.org/W2098312887","https://openalex.org/W2119458175","https://openalex.org/W2124109712","https://openalex.org/W2141403362","https://openalex.org/W2151179934","https://openalex.org/W2162599072","https://openalex.org/W2168148790","https://openalex.org/W2342422258","https://openalex.org/W2343184624","https://openalex.org/W2402774217","https://openalex.org/W2523086627","https://openalex.org/W2586115157","https://openalex.org/W2605673357","https://openalex.org/W2738856406","https://openalex.org/W2757344758","https://openalex.org/W2766293542","https://openalex.org/W2885275597","https://openalex.org/W2922384412","https://openalex.org/W2968599209","https://openalex.org/W2970107477","https://openalex.org/W2986313388","https://openalex.org/W2990733492","https://openalex.org/W4247665917","https://openalex.org/W4254230094"],"related_works":["https://openalex.org/W2809040876","https://openalex.org/W3133693098","https://openalex.org/W2081411187","https://openalex.org/W4394721961","https://openalex.org/W7096440942","https://openalex.org/W1993380685","https://openalex.org/W2897545894","https://openalex.org/W4212790439","https://openalex.org/W2004716659","https://openalex.org/W3165295054"],"abstract_inverted_index":{"Objectives:":[0],"Inadequately":[1],"controlled":[2],"symptoms":[3],"and":[4,31,46,55,66,126,145,151,169,176,224,235,244,248,284,293],"associated":[5],"impaired":[6],"functioning":[7],"have":[8],"a":[9,80,291],"significant":[10,193],"negative":[11],"impact":[12,27],"on":[13,36,190],"caregivers":[14,299],"of":[15,28,57,91,103,134,188,201,279,296,300],"children":[16,94,189,301],"with":[17,98,302],"attention-deficit/hyperactivity":[18],"disorder":[19],"(ADHD).":[20],"This":[21],"study":[22],"aimed":[23],"to":[24,62,67,130,164,289],"assess":[25],"the":[26,41,53,58,104,242,245,285],"evening-dosed,":[29],"delayed-release":[30],"extended-release":[32],"methylphenidate":[33],"(DR/ER-MPH)":[34],"treatment":[35,203,281],"caregiver":[37],"strain,":[38],"measured":[39],"by":[40],"Caregiver":[42],"Strain":[43],"Questionnaire":[44],"(CGSQ),":[45],"present":[47],"post":[48,107],"hoc":[49,108],"psychometric":[50],"analyses":[51],"assessing":[52],"reliability":[54,116,227],"validity":[56,123],"CGSQ,":[59],"its":[60],"ability":[61],"detect":[63],"change":[64,153],"(responsiveness),":[65],"derive":[68],"responder":[69],"definitions.":[70],"Methods:":[71],"The":[72,214,250],"CGSQ":[73,105,183,196,215,243,255,272,286],"was":[74,258,287],"an":[75],"exploratory":[76],"efficacy":[77],"endpoint":[78],"in":[79,93,132,195,298],"phase":[81],"3,":[82],"3-week,":[83],"randomized,":[84],"double-blind,":[85],"multicenter,":[86],"placebo-controlled,":[87],"forced-dose":[88],"titration":[89],"trial":[90,305],"DR/ER-MPH":[92,168,174,191,202,280],"aged":[95],"6\u201312":[96],"years":[97],"ADHD":[99,135],"(NCT02520388).":[100],"Psychometric":[101],"properties":[102],"evaluated":[106],"included":[109],"internal":[110,218],"consistency":[111,219],"using":[112,117,156],"Cronbach's":[113],"alpha;":[114],"test/retest":[115,226],"intraclass":[118],"correlation":[119],"coefficients":[120],"(ICCs);":[121],"construct":[122],"(known":[124],"groups":[125,179],"convergent/divergent":[127,233],"validity);":[128],"responsiveness":[129,236],"changes":[131],"assessments":[133],"severity":[136],"(ADHD":[137],"Rating":[138],"Scale-IV":[139],"[ADHD-RS-IV],":[140],"Conners'":[141],"Global":[142,147],"Index\u2013Parent":[143],"[CGI-P],":[144],"Clinical":[146,304],"Impression\u2014Severity":[148],"[CGI-S]/CGI\u2014Improvement":[149],"[CGI-I]);":[150],"meaningful":[152],"threshold":[154],"(MCT)":[155],"receiver":[157],"operating":[158],"characteristic":[159],"curves,":[160],"which":[161],"were":[162,237],"used":[163],"compare":[165],"response":[166],"between":[167,241],"placebo":[170,177,205],"groups.":[171],"Results:":[172],"Randomized":[173],"(54.5)":[175],"(54.9)":[178],"had":[180],"similar":[181],"mean":[182,251],"scores":[184,197,273],"at":[185],"screening.":[186],"Caregivers":[187],"reported":[192],"reductions":[194],"after":[198,276],"3":[199,277],"weeks":[200,278],"versus":[204,282],"(least-squares":[206],"mean:":[207],"41.2":[208],"vs.":[209,263,266],"49.1;":[210],"p":[211,268],"<":[212],"0.001).":[213],"demonstrated":[216,238],"strong":[217],"(Cronbach's":[220],"alpha":[221],"=":[222,229,269],"0.93)":[223],"good":[225],"(ICC":[228],"0.72).":[230],"Known":[231],"groups,":[232],"validity,":[234],"from":[239],"relationships":[240],"CGI-S,":[246],"ADHD-RS-IV,":[247],"CGI-P.":[249],"anchor-based":[252],"MCT":[253],"for":[254],"total":[256],"score":[257],"estimated":[259],"as":[260],"\u22129.0":[261],"(DR/ER-MPH":[262],"placebo:":[264],"53.2%":[265],"29.9%":[267],"0.003).":[270],"Conclusions:":[271],"significantly":[274],"decreased":[275],"placebo,":[283],"found":[288],"be":[290],"valid":[292],"reliable":[294],"measure":[295],"strain":[297],"ADHD.":[303],"registration":[306],"identification":[307],"number:":[308],"NCT02520388.":[309]},"counts_by_year":[{"year":2026,"cited_by_count":2},{"year":2025,"cited_by_count":2},{"year":2024,"cited_by_count":3},{"year":2023,"cited_by_count":1}],"updated_date":"2026-11-12T12:28:57.059296","created_date":"2021-04-13T00:00:00"}